文献速递头颈外科咽喉与嗓音

饮水试验对头颈癌患者吞咽困难的诊断价值:系统评价与Meta分析

Diagnostic value of water swallow test for dysphagia in patients with head and neck cancer: A systematic review and meta-analysis.
PubMed 文献 · Head Neck · 2024-03-06

该系统评价与Meta分析共纳入7篇文章、8个研究组、691例患者,评估饮水试验(WST)对头颈癌(HNC)患者吞咽困难的诊断效能。合并敏感度0.82、特异度0.79、AUC 0.86,但研究间存在显著异质性;鼻咽癌患者及放化疗患者的诊断效能较低。

要点

  • 饮水试验诊断头颈癌患者吞咽困难的合并敏感度0.82、特异度0.79、AUC 0.86。
  • 鼻咽癌患者合并敏感度仅0.40、AUC 0.50,低于其他头颈癌部位。
  • 放疗或放化疗患者敏感度0.49、特异度0.66、AUC 0.64,低于手术患者。

核心结论

  • 饮水试验对头颈癌患者吞咽困难检测具有较好的敏感度和特异度,但诊断价值可能因肿瘤部位、治疗方式和所用饮水试验版本等因素而异。

研究设计与样本

  • 系统检索截至2023年8月1日数据库中关于饮水试验筛查头颈癌患者吞咽困难的研究。
  • 采用QUADAS-2工具对纳入研究进行质量评价。
  • 共纳入7篇文章、8个研究组,涉及691例患者的分析。
  • 计算合并敏感度、特异度、阳性似然比、阴性似然比、诊断比值比和受试者工作特征曲线下面积(AUC)。

主要发现

  • 饮水试验诊断头颈癌患者吞咽困难的合并敏感度为0.82(95% CI [0.64, 0.92]),特异度为0.79(95% CI [0.70, 0.86]),阳性似然比为4.00(95% CI [2.51, 6.36]),阴性似然比为0.22(95% CI [0.10, 0.50]),诊断比值比为17.94(95% CI [5.56, 57.92]),AUC为0.86(95% CI [0.83, 0.89])。
  • Meta回归分析显示,合并敏感度与肿瘤部位和治疗密切相关,合并特异度与治疗和版本密切相关。
  • 亚组分析显示,饮水试验诊断鼻咽癌患者吞咽困难的合并敏感度为0.40(95% CI [0.26, 0.56]),AUC为0.50,低于其他头颈癌部位。
  • 饮水试验在手术患者中表现优于放疗或放化疗患者,放疗或放化疗患者的敏感度、特异度和AUC分别为0.49(95% CI [0.36, 0.61])、0.66(95% CI [0.59, 0.72])和0.64。
  • 改良版饮水试验的特异度为0.82(95% CI [0.75, 0.87]),常规版为0.68(95% CI [0.61, 0.74])。

关键数值与推荐

  • 饮水试验诊断头颈癌患者吞咽困难的合并敏感度0.82(95% CI [0.64, 0.92])、特异度0.79(95% CI [0.70, 0.86])、AUC 0.86(95% CI [0.83, 0.89])。
  • 鼻咽癌患者合并敏感度0.40(95% CI [0.26, 0.56])、AUC 0.50。
  • 放疗或放化疗患者敏感度0.49(95% CI [0.36, 0.61])、特异度0.66(95% CI [0.59, 0.72])、AUC 0.64。
  • 改良版饮水试验特异度0.82(95% CI [0.75, 0.87]),常规版特异度0.68(95% CI [0.61, 0.74])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究间观察到显著异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The diagnostic efficacy of the water swallow test (WST) is relatively robust for patients with neurogenic dysphagia; however, its diagnostic performance in identifying dysphagia among patients with HNC varies across studies. Our study aims to assess the diagnostic value of the WST for detecting dysphagia in patients with HNC. Systematic retrieval of studies on the use of WST for screening dysphagia in patients with HNC from databases up to August 1, 2023. Quality assessment of the included studies was performed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Calculate the pooled sensitivity, specificity, positive likelihood ratio (LR), negative LR, diagnostic odds ratio (DOR), and area under the receiver operating characteristic curve (AUC) to evaluate the screening ability of WST for dysphagia. A total of seven articles, encompassing eight study groups, were included, involving the analysis of 691 patients. The meta-analysis results demonstrate that the WST has a combined sensitivity, specificity, positive LR, negative LR, DOR, and AUC for diagnosing dysphagia in patients with HNC of 0.82 (95% CI [0.64, 0.92]), 0.79 (95% CI [0.70, 0.86]), 4.00 (95% CI [2.51, 6.36]), 0.22 (95% CI [0.10, 0.50]), 17.94 (95% CI [5.56, 57.92]), and 0.86 (95% CI [0.83, 0.89]), respectively. Significant heterogeneity was observed among the included studies. Meta-regression analysis showed that the pooled sensitivity of tumor sites and treatment was closely related, while the pooled specificity of treatment and version was closely related. The subgroup analysis showed that the WST's pooled sensitivity for diagnosing dysphagia in patients with nasopharyngeal cancer was 0.40 (95% CI [0.26, 0.56]), with an AUC of 0.50, lower than in other HNC sites. The WST performed better in surgical patients than in those undergoing radiotherapy (RT) or chemoradiotherapy (CRT), with lower sensitivity, specificity, and AUC values of 0.49 (95% CI [0.36, 0.61]), 0.66 (95% CI [0.59, 0.72]), and 0.64, respectively, for RT or CRT patients. The modified WST version showed different specificity values of 0.82 (95% CI [0.75, 0.87]), compared to the regular version of 0.68 (95% CI [0.61, 0.74]). Additionally, Deek's test indicated the absence of publication bias in this study (p = 0.32). The WST demonstrates favorable sensitivity and specificity in detecting dysphagia among patients with HNC. However, the diagnostic value may vary depending on factors such as tumor sites, treatment, and the specific version of the WST used.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Wang Y, Zhu Y, et al. Diagnostic value of water swallow test for dysphagia in patients with head and neck cancer: A systematic review and meta-analysis. Head Neck. 2024. PMID: 38445384. doi:10.1002/hed.27713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。